PET/MR Imaging: Current and Emerging Applications (eBook)
IX, 144 Seiten
Springer International Publishing (Verlag)
978-3-319-69641-6 (ISBN)
Lala Umutlu PD Dr. med. graduated from Heinrich-Heine Universität in Düsseldorf, Germany in 2006. She was trained in radiology at the Department of Diagnostic and Interventional Radiology and Neuroradiology at the University Hospital Essen. After receiving her habilitation (Venia legendi) on ultra-highfield whole-body MR imaging in 2013, her focus of scientific research interest expanded by hybrid molecular imaging, with a main focus on PET/MRI in oncology and malignancies of the female pelvis in particular. Dr. Umutlu serves as the Vice Chair of the Department of Diagnostic and Interventional Radiology and Neuroradiology of the University Hospital Essen as well as the Head of the Clinical PET/MRI and the Ultrahighfield research unit. As a member of various societies including the European Society of Radiology and a faculty member of the European Society for Magnetic Resonance Imaging in Medicine and Biology, she is also involved in training programs on PET/MRI and female oncologic MR imaging.
Herrmann, Ken Prof. Dr. graduated from Charité Universitätsmedizin in Berlin, Germany in 2004 including stays at the Universite de Lausanne, Universidad Austral de Chile in Valdivia, and Memorial Sloan-Kettering Cancer Center in New York. Dr. Herrmann was trained in nuclear medicine at Technische Universität München under the guidance of Professor Markus Schwaiger. Dr. Herrmann received an executive MBA of the University of Zürich. Since 2011, he has been a faculty member of the Department of Molecular and Medical Pharmacology of the University of California, Los Angeles (UCLA). In addition, Dr. Herrmann served from 2012 to 2016 as Vice Chair of Nuclear Medicine at Universitätsklinikum Würzburg. In 2016 he was appointed Chair of Nuclear Medicine at Universitätsklinikum Essen, Germany. Dr. Herrmann's research focuses on hybrid molecular imaging including PET/CT and PET/MRI and its clinical applications, on radionuclide theranostics, and on PET-based response assessment to oncologic therapies.
Lala Umutlu PD Dr. med. graduated from Heinrich-Heine Universität in Düsseldorf, Germany in 2006. She was trained in radiology at the Department of Diagnostic and Interventional Radiology and Neuroradiology at the University Hospital Essen. After receiving her habilitation (Venia legendi) on ultra-highfield whole-body MR imaging in 2013, her focus of scientific research interest expanded by hybrid molecular imaging, with a main focus on PET/MRI in oncology and malignancies of the female pelvis in particular. Dr. Umutlu serves as the Vice Chair of the Department of Diagnostic and Interventional Radiology and Neuroradiology of the University Hospital Essen as well as the Head of the Clinical PET/MRI and the Ultrahighfield research unit. As a member of various societies including the European Society of Radiology and a faculty member of the European Society for Magnetic Resonance Imaging in Medicine and Biology, she is also involved in training programs on PET/MRI and female oncologic MR imaging.Herrmann, Ken Prof. Dr. graduated from Charité Universitätsmedizin in Berlin, Germany in 2004 including stays at the Universite de Lausanne, Universidad Austral de Chile in Valdivia, and Memorial Sloan-Kettering Cancer Center in New York. Dr. Herrmann was trained in nuclear medicine at Technische Universität München under the guidance of Professor Markus Schwaiger. Dr. Herrmann received an executive MBA of the University of Zürich. Since 2011, he has been a faculty member of the Department of Molecular and Medical Pharmacology of the University of California, Los Angeles (UCLA). In addition, Dr. Herrmann served from 2012 to 2016 as Vice Chair of Nuclear Medicine at Universitätsklinikum Würzburg. In 2016 he was appointed Chair of Nuclear Medicine at Universitätsklinikum Essen, Germany. Dr. Herrmann’s research focuses on hybrid molecular imaging including PET/CT and PET/MRI and its clinical applications, on radionuclide theranostics, and on PET-based response assessment to oncologic therapies.
Current status and future applications.- Cardiac imaging.- Prostate imaging.- Oncology.- Female pelvis imaging.- Breast imaging.- Brain.-Pediatric.- Inflammatory.- Technical improvements.
Erscheint lt. Verlag | 13.2.2018 |
---|---|
Zusatzinfo | IX, 144 p. 63 illus., 59 illus. in color. |
Verlagsort | Cham |
Sprache | englisch |
Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete |
Schlagworte | brain imaging • Breast Imaging • Cardiac Imaging • Clinical Invitations • Female Pelvis Imaging • Hybrid Imaging • Inflammatory Imaging • Oncology • Pediatric Imaging • rostate Imaging • Simultaneous PET/MRI • Technical Imrovements |
ISBN-10 | 3-319-69641-6 / 3319696416 |
ISBN-13 | 978-3-319-69641-6 / 9783319696416 |
Haben Sie eine Frage zum Produkt? |
Größe: 9,4 MB
DRM: Digitales Wasserzeichen
Dieses eBook enthält ein digitales Wasserzeichen und ist damit für Sie personalisiert. Bei einer missbräuchlichen Weitergabe des eBooks an Dritte ist eine Rückverfolgung an die Quelle möglich.
Dateiformat: PDF (Portable Document Format)
Mit einem festen Seitenlayout eignet sich die PDF besonders für Fachbücher mit Spalten, Tabellen und Abbildungen. Eine PDF kann auf fast allen Geräten angezeigt werden, ist aber für kleine Displays (Smartphone, eReader) nur eingeschränkt geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen dafür einen PDF-Viewer - z.B. den Adobe Reader oder Adobe Digital Editions.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen dafür einen PDF-Viewer - z.B. die kostenlose Adobe Digital Editions-App.
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich